TABLE 1.
Participant characteristics.
| Variable (unit) | Glucoraphanin (n = 35) | Placebo (n = 35) | P-value |
| Sex (male/female) | 26/9 (74.3%) | 26/9 (74.3%) | 1.0 |
| Age (years) | 52.7 (5.3) | 52.5 (4.8) | 0.89 |
| Height (cm) | 168.9 (8.2) | 165.6 (6.2) | 0.063 |
| Weight (kg) | 72.3 (15.7) | 70.1 (12.8) | 0.52 |
| BMI (kg/m2) | 25.1 (4.2) | 25.4 (3.7) | 0.75 |
| Body fat (%) | 25.8 (8.5) | 26.2 (5.6) | 0.84 |
| Systolic blood pressure (mmHg) | 127.9 (17.5) | 126.7 (15.5) | 0.75 |
| Diastolic blood pressure diastolic (mmHg) | 85.6 (12.7) | 84.9 (11.4) | 0.79 |
| Heart rate (bpm) | 76.3 (11.7) | 74.0 (12.1) | 0.42 |
| ALT (U/L) | 38.0 (33.5–44.0) | 39.0 (35.0–46.5) | 0.37 |
| AST (U/L) | 28.0 (24.0–33.0) | 29.0 (24.5–33.5) | 0.44 |
| γ-GTP (U/L) | 34.0 (27.5–52.5) | 44.0 (31.0–68.5) | 0.21 |
Data are expressed as numbers (percentage) or mean (standard deviation).
ALT, AST, and γ-GTP values are expressed as median (interquartile range).
The chi-square test was used to compare sex, and t-tests were used to compare other variables.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GTP, gamma-glutamyl transferase; BMI, body mass index.